Sign in

Relay Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.02 0.01 0.03 0.00 0.00 0.08 0.00 0.00
Cost of revenue 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.01 0.01 0.03 0.00 0.00 0.08 0.00 0.00
Total operating expenses + 0.31 0.38 0.40 0.30 0.37 0.13 0.08 0.05
Operating income -0.30 -0.37 -0.37 -0.30 -0.36 -0.06 -0.08 -0.05
Non-operating income (net) 0.03 0.03 0.03 0.01 0.00 0.00 0.01 0.00
Income before tax -0.28 -0.34 -0.34 -0.29 -0.36 -0.05 -0.08 -0.05
Income tax expense -0.34 -0.04 -0.04 0.13 0.00 -0.01 0.00
Net income -0.28 -0.34 -0.34 -0.29 -0.36 -0.05 -0.07 -0.05
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total revenue 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.09 0.08 0.06 0.07 0.06 0.05 0.05 0.04 0.05 0.03 0.00 0.02 0.02 0.02
Gross profit 0.00 0.01 0.00 0.00 0.01 -0.01 0.00 0.00 0.01 0.00 -0.06 -0.09 -0.08 -0.06 -0.07 -0.06 -0.05 -0.05 -0.04 -0.04 -0.03 0.08 -0.02 -0.02 -0.02
Total operating expenses + 0.08 0.07 0.08 0.08 0.09 0.08 0.10 0.10 0.10 0.09 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.15 0.01 0.05 0.04 0.03 0.03 0.03 0.02 0.02 0.02
Operating income -0.08 -0.06 -0.08 -0.08 -0.08 -0.08 -0.10 -0.10 -0.09 -0.09 -0.07 -0.11 -0.10 -0.07 -0.09 -0.08 -0.06 -0.07 -0.06 -0.19 -0.04 0.03 -0.04 -0.03 -0.03 -0.03 -0.02 -0.02 -0.02
Non-operating income (net) 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.07 -0.05 -0.07 -0.07 -0.08 -0.08 -0.09 -0.09 -0.08 -0.08 -0.07 -0.10 -0.09 -0.07 -0.08 -0.08 -0.06 -0.07 -0.06 -0.19 -0.04 0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.01
Income tax expense 0.00 0.02 0.00 -0.01 -0.01 -0.02 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.07 -0.05 -0.07 -0.07 -0.08 -0.08 -0.09 -0.09 -0.08 -0.08 -0.07 -0.10 -0.09 -0.07 -0.08 -0.08 -0.06 -0.07 -0.06 -0.19 -0.04 0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.01
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.55 0.78 0.75 1.85 0.96 0.68 0.36 0.42
Accounts receivable, net 0.00 0.01 0.00 0.08
Inventories 0.01 -0.68 -0.24
Other current assets 0.02 0.03 0.00 0.00 0.01 0.01 0.00 0.00
Total current assets 0.58 0.81 0.77 1.02 0.98 0.77 0.36 0.42
Total non-current assets + 0.04 0.06 0.07 0.08 0.03 0.03 0.03 0.00
Total assets 0.62 0.87 0.84 1.10 1.01 0.80 0.39 0.43
Total current liabilities + 0.03 0.05 0.03 0.06 0.02 0.01 0.01 0.01
Total non-current liabilities + 0.03 0.04 0.06 0.09 0.09 0.02 0.56 0.53
Total liabilities 0.05 0.09 0.09 0.15 0.11 0.04 0.57 0.54
Total stockholders' equity + 0.57 0.78 0.75 0.95 0.90 0.76 -0.18 -0.11
Common shares outstanding 172 143 123 112 95 90 4 2
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total cash and short-term investments + 0.64 0.55 0.60 0.66 0.71 0.78 0.84 0.69 0.75 0.75 0.81 0.87 0.94 1.85 1.05 0.84 0.90 0.96 0.62 0.67 0.73 0.68 0.71 0.31 0.33 0.36 0.00 0.00 0.42
Accounts receivable, net 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.01 0.08
Inventories 0.02 0.01 0.01 0.01 0.02 0.00 0.00 0.00 0.00
Other current assets 0.02 0.02 0.03 0.02 0.03 0.03 0.03 0.02 0.02 0.00 0.02 0.01 0.00 0.00 0.03 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total current assets 0.66 0.58 0.62 0.68 0.74 0.81 0.87 0.70 0.77 0.77 0.83 0.88 0.96 1.02 1.09 0.86 0.92 0.98 0.64 0.68 0.74 0.77 0.72 0.32 0.34 0.36 0.42
Total non-current assets + 0.04 0.04 0.05 0.05 0.06 0.06 0.06 0.07 0.07 0.07 0.08 0.08 0.08 0.08 0.08 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 -0.42
Total assets 0.70 0.62 0.67 0.73 0.80 0.87 0.93 0.77 0.84 0.84 0.91 0.96 1.04 1.10 1.17 0.89 0.95 1.01 0.67 0.71 0.77 0.80 0.75 0.35 0.37 0.39
Total current liabilities + 0.03 0.03 0.03 0.03 0.04 0.05 0.05 0.05 0.04 0.03 0.05 0.07 0.07 0.06 0.07 0.04 0.04 0.02 0.03 0.03 0.02 0.01 0.02 0.01 0.01 0.01
Total non-current liabilities + 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.05 0.06 0.06 0.08 0.08 0.08 0.09 0.10 0.07 0.07 0.09 0.07 0.07 0.02 0.02 0.02 0.56 0.02 0.56
Total liabilities 0.06 0.05 0.06 0.06 0.08 0.09 0.09 0.09 0.10 0.09 0.13 0.15 0.15 0.15 0.17 0.11 0.11 0.11 0.10 0.10 0.04 0.04 0.04 0.57 0.03 0.57
Total stockholders' equity + 0.64 0.57 0.61 0.67 0.72 0.78 0.84 0.68 0.75 0.75 0.78 0.81 0.88 0.95 1.00 0.78 0.84 0.90 0.57 0.62 0.73 0.76 0.71 -0.23 0.34 -0.18 0.42
Common shares outstanding 180 172 172 171 169 167 140 133 131 123 122 122 121 121 111 109 108 103 93 92 90 90 71 4 4 4 4 3 3
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.24 -0.25 -0.30 -0.23 -0.07 -0.10 -0.07 -0.04
Cash flow from investing + 0.19 -0.04 0.26 -0.19 -0.48 0.08 -0.32 0.00
Cash flow from financing + 0.00 0.27 0.03 0.29 0.39 0.43 0.01 0.39
Change in cash -0.04 -0.02 -0.01 -0.13 -0.17 0.41 -0.38 0.35
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Operating cash flow + -0.05 -0.04 -0.06 -0.06 -0.07 -0.06 -0.08 -0.07 -0.05 -0.09 -0.08 -0.07 -0.07 -0.06 -0.07 -0.06 -0.05 -0.04 -0.05 -0.03 0.05 -0.04 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.01
Cash flow from investing + 0.03 0.04 0.04 0.08 0.04 0.03 -0.13 0.05 0.01 0.06 0.07 0.05 0.08 -0.15 0.03 0.04 -0.11 -0.29 0.02 0.03 -0.23 -0.08 0.02 0.09 0.05 0.04 0.01 -0.36 0.00
Cash flow from financing + 0.14 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.05 0.02 0.01 0.00 0.00 0.00 0.29 0.00 0.00 0.38 0.00 0.00 0.00 0.00 0.43 0.00 0.00 0.00 0.00 0.00 0.01
Change in cash 0.12 -0.01 -0.02 0.02 -0.03 -0.03 0.02 -0.02 0.01 -0.01 0.01 -0.02 0.01 -0.20 0.25 -0.01 -0.16 0.05 -0.03 0.00 -0.18 -0.11 0.42 0.07 0.03 0.01 -0.01 -0.37 -0.01
4 days ago

Relay Therapeutics, Inc. (RLAY) - Operating Cashflow

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Change In Inventory

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Net Income

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Stock Based Compensation

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Cashflow From Financing

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Cashflow From Investment

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Capital Expenditures

1Y 2Y 5Y Max
9 days ago

Relay Therapeutics, Inc. (RLAY) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
9 days ago